Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Silo Pharma, Inc. (SILO) had Normalized Pre-Tax Income of $-1.65M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.02M |
|
$-1.65M |
|
$0.02M |
|
$-0.00M |
|
$1.61M |
|
$-1.59M |
|
$-0.05M |
|
$-1.65M |
|
|
Normalized Pre-Tax Income |
$-1.65M |
$-1.65M |
|
$-1.65M |
|
$-1.65M |
|
$-1.65M |
|
$-1.59M |
|
$-1.56M |
|
0.91M |
|
0.91M |
|
$-1.80 |
|
$-1.80 |
|
| Balance Sheet Financials | |
$6.80M |
|
-- |
|
$0.21M |
|
$7.02M |
|
$0.70M |
|
-- |
|
$0.63M |
|
$1.34M |
|
$5.68M |
|
$5.47M |
|
$5.68M |
|
1.08M |
|
| Cash Flow Statement Financials | |
$-0.82M |
|
$-0.02M |
|
-- |
|
$4.75M |
|
$3.90M |
|
$-0.85M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.77% |
|
-8846.44% |
|
-8846.44% |
|
-- |
|
-9137.45% |
|
-9137.45% |
|
$-0.78M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-28.99% |
|
-30.13% |
|
-23.47% |
|
-28.99% |
|
$5.24 |
|
$-0.85 |
|
$-0.90 |
|